Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Dirigidas en Enfermedades Reumáticas

Biobadaser Fase III

Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’study)

11/03/2024

Aymon, R., Mongin, D., Bergstra, S. A., Choquette, D., Codreanu, C., De Cock, D., ... & Lauper, K.

Annals of the rheumatic diseases.

https://doi.org/10.1136/ard-2023-224670 

doi: 10.1136/ard-2023-224670